Skip to content

Cell-Free DNA BCT

by Streck 2 variants

De Novo DEN200001

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN200001 Date7 Aug 2020DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
QMA
FDA applicant
Streck, Inc.
Device Class
Class II
Regulation
21 CFR Part 862.1676
Advisory Committee
Clinical Chemistry
FDA Decision
DENG De Novo granted

Other devices from Streck

  • Cell-Free DNA BCT CE

    Class A

  • Xn Check Bf

    Class II

  • Cell-Free DNA BCT

    Class II

  • Xn Check

    Class II

  • Xn Cal

    Class II

  • Xn-L Check

    Class II

See all devices from Streck →